<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001295913</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001579428</issuerCik>
      <issuerName>Axsome Therapeutics, Inc.</issuerName>
      <secFileNumber>001-37635</secFileNumber>
      <issuerAddress>
        <com:street1>ONE WORLD TRADE CENTER, 22ND FLOOR</com:street1>
        <com:city>NEW YORK</com:city>
        <com:stateOrCountry>NY</com:stateOrCountry>
        <com:zipCode>10007</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(212) 332-3241</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Saad Mark E</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Charles Schwab &amp; Co., Inc.</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>11016</noOfUnitsSold>
      <aggregateMarketValue>1005843.00</aggregateMarketValue>
      <noOfUnitsOutstanding>48000205</noOfUnitsOutstanding>
      <approxSaleDate>09/11/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>09/11/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Employee Stock Option Exercise</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Axsome Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>11016</amountOfSecuritiesAcquired>
      <paymentDate>09/11/2024</paymentDate>
      <natureOfPayment>Broker Payment for Cashless Exercise</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>09/11/2024</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>12/14/2023</planAdoptionDate>
      </planAdoptionDates>
      <signature>MARK E SAAD</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2891}]
144
0001295913
XXXXXXXX
LIVE
0001579428
Axsome Therapeutics, Inc.
001-37635
ONE WORLD TRADE CENTER, 22ND FLOOR
NEW YORK
NY
10007
(212) 332-3241
Saad Mark E
Director
Common
Charles Schwab & Co., Inc.
3000 Schwab Way
Westlake
TX
76262
11016
1005843.00
48000205
09/11/2024
NASDAQ
Common
09/11/2024
Employee Stock Option Exercise
Axsome Therapeutics, Inc.
N
11016
09/11/2024
Broker Payment for Cashless Exercise
Y
09/11/2024
12/14/2023
MARK E SAAD